HIV 1 News and Research

RSS

White House to expand federal marketplace insurance plan standards in 2015, broaden choices

The Obama administration will rely less on state insurance regulators and private groups in determining which plans will meet standards to sell insurance on the federal marketplace.

18 Mar 2014

Patients with both HIV and hepatitis C have 80% higher rates of serious liver disease

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from antiretroviral therapy (ART) to treat HIV.

18 Mar 2014

Binghamton University plays role in improving Rwandan’s healthcare system

Twenty years after the Rwandan Genocide left nearly 1 million dead and 2 million homeless, Binghamton University is playing a role in improving the nation's healthcare. Karen Feltham, a clinical instructor in the Decker School of Nursing, spent the 2013 fall semester in Rwanda working with women in the Rwandan Midwives Association.

17 Mar 2014

Study shows effect of oral fungal yeast in inhibiting thrush

Scientists at Case Western Reserve School of Medicine and University Hospitals (UH) Case Medical Center have discovered how the beneficial fungal yeast, Pichia, holds at bay a harmful fungal yeast, Candida.

14 Mar 2014

Highlights: No-bid contract decision in Calif.; Fla. hospital Medicaid settlement; navigator restrictions in Kan.

A selection of health policy stories from California, Florida, Kansas, New York, Virginia, Maryland, Wisconsin and Minnesota.

13 Mar 2014

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

Although community network studies show that sexual relationships occur between members of "risk groups" -- men who have sex with other men (MSM), people who inject drugs (PWID), non-injection drug users (NIDU) -- and heterosexuals, researchers at New York University's Center for Drug Use and HIV Research (CDUHR) note that little research has been done to help explain how HIV epidemics and programs in one population affect others and how to reduce the risks of transmission.

13 Mar 2014

First Edition: March 12, 2014

Today's headlines include stories about the Obama administration's latest tallies regarding how many Americans have signed up for Obamacare coverage and the outcome of a Florida special election that was marked by health law themes.

12 Mar 2014

EPFL sets up foundation to release antibiotic for tuberculosis

Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.

12 Mar 2014

Parasites in human are most likely to interact via food source

Over 1,400 species of parasites - viruses, bacteria, fungi, intestinal worms and protozoa - are able to infect humans. In most cases, the right medicine against a parasite cures the patient.

12 Mar 2014

UCSF School of Medicine ranked fourth nationwide in research and primary care education

UC San Francisco's School of Medicine ranked fourth nationwide in both research and primary care education this year, according to a new survey conducted by U.S. News & World Report.

11 Mar 2014

Researchers suggest potential treatment target for HCMV infection

Discovering where a common virus hides in the body has been a long-term quest for scientists. Up to 80 percent of adults harbor the human cytomegalovirus (HCMV), which can cause severe illness and death in people with weakened immune systems.

11 Mar 2014

As enrollment deadline looms, subsidies still confuse some consumers

The Wall Street Journal unveils a calculator to help explain these tax credits, or subsidies, while the CT Mirror looks at last-minute consumer questions.

11 Mar 2014

One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists.

11 Mar 2014

Highlights: Calif. retiree health costs rise; more abortion clinic closings in Texas; Wash. insurance bills roadblock

A selection of health policy stories from California, Texas, Washington state, Illinois, Virginia and Georgia.

10 Mar 2014

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

"Sheriff Ashe," [the waitress] began. "My daughter is in your jail." She then told me her daughter's story. "Laura," as I'll call her here, was a bright and sociable girl who, after graduating from high school, went on to community college.

10 Mar 2014

New method of protecting women from transmission of HIV is safe

Findings of an early phase clinical trial at the University of Alabama at Birmingham suggest that a possible new method of protecting women from the transmission of HIV is safe.

7 Mar 2014

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

Today Boehringer Ingelheim announced results from STARTVerso4 in patients with HCV/HIV co-infection. Hepatitis C viral cure 12 weeks after the conclusion of treatment (SVR12) was achieved by 72% of all patients in the trial. Patients were enrolled in either 120mg or 240mg faldaprevir dose groups.

6 Mar 2014

WHO launches new guidance to help countries provide contraception information and services

In advance of International Women's Day on 8 March 2014, WHO is launching new guidance to help countries ensure human rights are respected in providing more girls, women, and couples with the information and services they need to avoid unwanted pregnancies.

6 Mar 2014

Merck announces new data from ongoing C-WORTHY Study in HIV/HCV co-infected patients

Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.

5 Mar 2014

Haiti HIV program increases sexual health awareness and practices in women

New research from the University of Toronto shows that a little training can go a long way in a desperate situation.

5 Mar 2014

HIV 1 News and Research

White House to expand federal marketplace insurance plan standards in 2015, broaden choices

Patients with both HIV and hepatitis C have 80% higher rates of serious liver disease

Binghamton University plays role in improving Rwandan’s healthcare system

Study shows effect of oral fungal yeast in inhibiting thrush

Highlights: No-bid contract decision in Calif.; Fla. hospital Medicaid settlement; navigator restrictions in Kan.

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

First Edition: March 12, 2014

EPFL sets up foundation to release antibiotic for tuberculosis

Parasites in human are most likely to interact via food source

UCSF School of Medicine ranked fourth nationwide in research and primary care education

Researchers suggest potential treatment target for HCMV infection

As enrollment deadline looms, subsidies still confuse some consumers

One person's unique ability provides key insights into immune response to fight HIV

Highlights: Calif. retiree health costs rise; more abortion clinic closings in Texas; Wash. insurance bills roadblock

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

New method of protecting women from transmission of HIV is safe

Boehringer Ingelheim reports results from SVR12 Phase 3 trial in patients with HCV/HIV co-infection

WHO launches new guidance to help countries provide contraception information and services

Merck announces new data from ongoing C-WORTHY Study in HIV/HCV co-infected patients

Haiti HIV program increases sexual health awareness and practices in women

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest News